Journal of psychiatry & neuroscience : JPN
-
J Psychiatry Neurosci · Mar 2006
Meta Analysis Comparative StudyEfficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
Escitalopram is the most selective of the selective serotonin reuptake inhibitor (SSRI) antidepressants. Previous studies have suggested that escitalopram is superior to citalopram in efficacy. We conducted a meta-analysis of studies in which escitalopram was compared with other antidepressants to assess the relative efficacy of these agents. ⋯ In this meta-analysis, escitalopram showed significant superiority in efficacy compared with the active controls.